METHOD OF CORRECTION OF ANXIETY-DEPRESSIVE DISORDERS IN PATIENTS WITH SYSTEMIC CONNECTIVE TISSUE DISEASES

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to therapy, and concerns correction of anxiety-depressive disorders in patients with systemic connective tissue diseases. For this purpose, in addition to the traditional therapy of systemic connective tissue diseases, paroxetine is orally administered in an initial dose of 10 mg a day, followed by increasing dose to 20–30 mg a day. Duration of course is 3 months.;EFFECT: such mode of drug administration provides higher clinical effectiveness in the main disease combined with reducing depressive symptoms, including by increasing adherence to treatment.;1 cl, 2 ex